← SynDRA

PARSACLISIB

SynDRA canonical compound SYN0039709 — structure-anchored drug synonym record

All known targets

• PIK3CD

Mechanisms of action (all sources)

• PIK3CD INHIBITOR
• PI3-kinase p110-delta subunit inhibitor
• PI3K inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

• CYP1A2
• CYP2B6
• CYP2C19
• CYP2C8
• CYP2C9
• CYP2D6
• CYP3A4
• KCNH2
• PIK3CA
• PIK3CB
• PIK3CG

ATC classes

• L01E · PROTEIN KINASE INHIBITORS

Cross-references

• PubChem CID: 86677874
• ChEMBL: CHEMBL4297615
• DrugBank: DB14867
• KEGG: D11437
• Wikipedia: Parsaclisib
• TTD: DP1SE6

Synonyms

• INCB050465
• INCB-050465
• Parsaclisib free base
• UNII-OS7097575K
• 1426698-88-5 (free base)
• OS7097575K
• (4R)-4-{3-[(1S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl}pyrrolidin-2-one
• (4R)-4-(3-((1S)-1-(4-Amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
• Parsaclisib [INN]
• Parsaclisib [USAN]
• Parsaclisib (USAN/INN)
• Parsaclisib [USAN:INN]
• INCB050465 free base
• INCB-050465 free base
• CHEMBL4297615
• SCHEMBL14736228
• BDBM272573
• EX-A2638
• WHO 10589
• DB14867
• US10065963, 32c
• HY-109068
• CS-0033435
• D11437
• (R)-4-(3-((S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
• 2-Pyrrolidinone, 4-(3-((1S)-1-(4-amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)-, (4R)-
• IBI376
• parsaclisibum
• INCB50465
• RefChem:858696
• INCB-50465
• C20H22ClFN6O2
• Parsaclisib?
• PARSACLISIB [WHO-DD]
• orb1309280
• SCHEMBL30089288
• ZQPDJCIXJHUERQ-QWRGUYRKSA-N
• MFCD31692358
• AKOS040733972